Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,177,043
+$754,919 QoQ
Shares Held
84,644
+14.3% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 290 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. DNLI ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in DNLI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,177,043 | 84,644 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,422,124 | 74,069 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,003,246 | 60,766 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $796,189 | 54,834 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $806,914 | 57,678 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $415,517 | 30,564 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $977,220 | 47,950 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,755,198 | 60,254 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $999,225 | 43,033 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $812,078 | 39,575 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $532,422 | 24,810 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $297,401 | 14,416 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $419,071 | 14,201 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $238,417 | 10,348 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $207,712 | 7,469 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $223,668 | 7,288 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $208,217 | 7,075 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $218,112 | 6,780 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $232,276 | 5,208 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $262,743 | 5,208 | Shares | Sole | 2021-11-10 | |
| 2020-09-30 | $396,996 | 11,080 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||